Erika Secco

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

Paolo Macor, Erika Secco, Nelly Mezzaroba et al. · Leukemia · 2014 · 79 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +12

New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles

Nelly Mezzaroba, Sonia Zorzet, Erika Secco et al. · PLoS ONE · 2013 · 57 citations · Full text

Nanomedicine, Nanotherapeutics, Therapeutic Nanomaterials +12

In Vivo Biodistribution and Lifetime Analysis of Cy5.5-Conjugated Rituximab in Mice Bearing Lymphoid Tumor Xenograft Using Time-Domain Near-Infrared Optical Imaging

Stefania Biffi, Chiara Garrovo, Paolo Macor et al. · Molecular Imaging · 2008 · 40 citations · Full text

Engineering, Oncologic Imaging, Immunology +19

P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)

Claudio Tripodo, Ada Maria Florena, Paolo Macor et al. · Current Cancer Drug Targets · 2009 · 20 citations

Hematological Malignancy, Cancer Immunosurveillance, P-selectin Glycoprotein Ligand-1 +15

Endosperm-specific expression of human acid beta-glucosidase in a waxy rice

Tamara Patti, Bruno Bembi, Piero Cristin et al. · Rice · 2012 · 14 citations · Full text